SF3B1 and myelodysplastic syndrome: Previous studies employing GoT-Splice in patients with SF3B1-mutated MDS have revealed that mutant cells demonstrate preferential enrichment within the megakaryocytic–erythroid lineage, with significant expansion, specifically within erythroid progenitor populations [8,17].